Injecting cancer stem cells derived from GBM patients into cerebral organoids or genetic engineering of cerebral organoids by introducing HRasG12V and disrupting p53 initiated tumorigenesis that closely recapitulated patient GBMs (180, 181). Here, TP53 is linked to glioblastoma.